Incidence and outcomes of eating disorders during the COVID-19 pandemic

Maxime Taquet(Mansfield University), Paul J. Harrison(University of British Columbia), John Geddes(University of Oxford), Sierra Luciano(TriNetX (United States))

The British Journal of Psychiatry

July 27, 2021

10.1192/bjp.2021.105

Cited by 265

Related Papers

Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis

|The Lancet|2018|3.4k

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

|The Lancet Psychiatry|2021|2.2k

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

|The Lancet Psychiatry|2020|1.5k

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19

|PLoS Medicine|2021|983

Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients

|The Lancet Psychiatry|2022|722